Synthesis, Characterization, and Stability of Dealkylated Salen-Supported Aluminum Phosphates.

Three salen aluminum bromide compounds salen(tBu)AlBr (1) (salen = N,N'-ethylenebis(3,5-di-tert-butylsalicylideneimine)), salpen(tBu)AlBr (2) (salpen = N,N'-propylenebis(3,5-di-tert-butylsalicylideneimine)), and salophen(tBu)AlBr (3) (salophen = N,N'-o-phenylenenebis(3,5-di-tert-butylsalicylideneimine) were evaluated for their potential use as dealkylation agents with a series of organophosphates. These reactions led to the aluminum phosphate compounds containing six-coordinate aluminum centers and hydrolytically stable P-O-C bonds: 4 = [salen(tBu)AlOP(O)(OMe)2]n, 5 = [salen(tBu)AlOP(O)(OEt)2]n, 6 = [salen(tBu)AlOP(O)(OPh)2]n, 7 = [salophen(tBu)AlOP(O)(OMe)2]n, 8 = [salpen(tBu)AlOP(O)(OiPr)2]2, 9 = (salen(tBu)AlO)3PO, 10 = (salpen(tBu)AlO)3PO, 11 = (salophen(tBu)AlO)3PO. All the compounds were characterized by 1H, 13C, 27Al, and 31P NMR, IR, and mass spectrometry. Furthermore, compounds 4-8 were structurally characterized by single-crystal X-ray diffraction. The potential hydrolysis of these compounds was modeled with 4 and demonstrated the unique stability of the final product and ease of isolation.

Lewis acid-assisted detection of nerve agents in water.

The five-coordinate compound, Salen((t)Bu)Al(Ac), prepared in situ from Salen((t)Bu)AlBr and NH4Ac, forms Lewis acid-base adducts in aqueous solution with the G-type nerve agents, Sarin and Soman, and the VX hydrolysis product, ethylmethylphosphonate (EMPA). The resulting compounds, [Salen((t)Bu)Al(NA)](+)[Ac] (-) (with NA = Sarin, Soman, and EMPA) are sufficiently stable to be identified by ESI-MS. Molecular ion peaks were detected for every compound with little or no fragmentation. The distinctive MS signatures for the [Salen((t)Bu)Al(NA)](+) compounds provide a new technique for identifying nerve agents from aqueous solution. The energetics of the displacement of Ac(-) by the nerve agents to form [Salen((t)Bu)Al(NA)](+)[Ac](-) were determined computationally.

Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.

A major process-related impurity associated with the synthesis of ezetimibe was detected by LC-MS. The isolated impurity was found not to have been previously reported. Based on LC/MS/MS studies and accurate mass data, the structure of that impurity was proposed to be 2-(4-hydroxybenzyl)-N,5-bis-(4-fluorophenyl)-5-hydroxypentanamide. The postulated structure was unambiguously confirmed with the help of the NMR and IR analyses of a synthetically obtained sample. The chemical shift of the labile proton of that new entity was assigned by a 2D-NOESY NMR experiment. A rationalization for the formation of this impurity is provided.